Stock ECILC EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET
Add to a list
To use this feature you must be a member
Log inSign up

Company EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret

Equities

ECILC

TRAECILC91E0

Pharmaceuticals

Market Closed - Borsa Istanbul
Other stock markets
 16:05:21 28/06/2024 BST 		5-day change 1st Jan Change
51.35 TRY -0.29% Intraday chart for EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret -4.29% +16.81%
06-13 EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-17 EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS, formerly known as Eczacibasi Ilac Sanayi ve Ticaret A.S., (EIS) is a Turkey-based company active in the pharmaceutical industry through its subsidiaries, affiliates and joint ventures. Its product portfolio consists of drugs for human health, veterinary drugs and personal care products, such as body and facial creams, hair gels, deodorants and various other products. The Company is also engaged in real estate development and construction through its subsidiary, Eczacibasi Gayrimenkul Gelistirme ve Yatirim A.S., formerly known as Eczacibasi Insaat ve Ticaret A.S. Its subsidiaries also include Eczacibasi Ilac Ticaret A.S. (EIT), EHP Eczacibasi Health Care Products Joint Stock Co. (EHP), and Eczacibasi Gayrimenkul Gelistirme ve Yatirim A.S., among others. EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a member of Eczacibasi Group of Companies.

Number of employees: 1,137

Sales per Business

TRY in Million2021Weight2022Weight Delta
Healthcare
89.2 %
946 85.8 % 1,633 89.2 % +72.53%
Real Estate Development
10.8 %
157 14.2 % 198 10.8 % +25.92%

Sales per region

TRY in Million2021Weight2022Weight Delta
Turkey
118.9 %
1,425 129.1 % 2,176 118.9 % +52.75%
Sales Discounts
-25.6 %
-305 -27.7 % -469 -25.6 % +53.57%
Overseas
7.1 %
1 0.1 % 130 7.1 % +14,512.06%
Sales Returns
-0.3 %
-17 -1.5 % -6 -0.3 % -62.46%

Managers

Managers TitleAgeSince
Emin Fadillioglu CEO
 Chief Executive Officer - 31/08/22
Simay Agaçdiken Unal IRC
 Investor Relations Contact - 30/08/11

Members of the board

Members of the board TitleAgeSince
Ferit Bülent Eczacibasi CHM
 Chairman - 02/04/81
Atalay Muharrem Gümrah BRD
 Director/Board Member 57 11/04/18
Rahmi Faruk Eczacibasi BRD
 Director/Board Member 70 -
Seyfettin Sariçam BRD
 Director/Board Member - 08/04/20
Hasan Toker Alban BRD
 Director/Board Member 78 11/04/18
Zühal Atanan BRD
 Director/Board Member 70 31/03/18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 685,260,000 128,610,612 ( 18.77 %) 0 18.77 %

Shareholders

NameEquities%Valuation
Eczacibasi Family
50.62 %
346,845,461 50.62 % 569 M ₺
ECZACIBASI YATIRIM HOLDING ORTAKLIGI
30.62 %
209,803,928 30.62 % 344 M ₺
State Street Global Advisors Ltd.
0.0519 %
355,852 0.0519 % 583 341 ₺
Mercer Global Investments Europe Ltd.
0.002305 %
15,796 0.002305 % 25 894 ₺

Company contact information

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirim San ve Tic AS

Büyükdere Caddesi Ali Kahya Sokak, No. 5

34394, Istanbul

+90 212 350 80 00

http://www.eis.com.tr
address EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret(ECILC)

Group companies

NameCategory and Sector
Eip Eczacibasi Ilaç Pazarlama AS

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
51.5 TRY
Average target price
53.5 TRY
Spread / Average Target
+3.88%
Consensus

Sector Other Pharmaceuticals

1st Jan change Capi.
EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET Stock EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret
+16.81% 1.07B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+56.64% 819B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.42% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.38% 329B
ABBVIE INC. Stock AbbVie Inc.
+9.41% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+2.04% 225B
NOVARTIS AG Stock Novartis AG
+13.31% 217B
AMGEN INC. Stock Amgen Inc.
+8.37% 168B
PFIZER, INC. Stock Pfizer, Inc.
-2.94% 158B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ECILC Stock
  4. Company EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret